| Identification | Back Directory | [Name]
6-Chloro-4-phenyl-2-(1-piperidinyl)-3-(2H-tetrazol-5-yl)quinoline | [CAS]
1433901-75-7 | [Synonyms]
RO6806051
6-Chloro-4-phenyl-2-(1-piperidinyl)-3-(2H-tetrazol-5-yl)quinoline
Quinoline, 6-chloro-4-phenyl-2-(1-piperidinyl)-3-(2H-tetrazol-5-yl)-
RO6806051 6-chloro-4-phenyl-2-(piperidin-1-yl)-3-(1H-tetrazol-5-yl)quinoline | [Molecular Formula]
C21H19ClN6 | [MOL File]
1433901-75-7.mol | [Molecular Weight]
390.87 |
| Chemical Properties | Back Directory | [Boiling point ]
652.9±65.0 °C(Predicted) | [density ]
1.349±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
1.88±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
RO6806051 (compound12) is a potent dual fatty acid binding protein 4 and 5 (FABP4 and FABP5) inhibitor with good selectivity and absorption, distribution, metabolism and excretion (eADME) properties[1]. | [References]
[1] Kühne H, et al. Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors. Bioorg Med Chem Lett. 2016 Oct 15;26(20):5092-5097. DOI:10.1016/j.bmcl.2016.08.071 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|